Biotech CLASS ACTION UPDATE for EIGR, AFRM and SGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders January 4, 2023
Biotech ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX January 4, 2023
Biotech Eiger BioPharmaceuticals Class Action Deadline: Submit Your Losses to Johnson Fistel January 4, 2023
Biotech Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma January 4, 2023
Biotech Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol January 4, 2023
Biotech Immutep Achieves 50% Enrollment Milestone in Randomised Phase IIb TACTI-003 Trial for First Line Head & Neck Cancer January 4, 2023
Biotech Cidara Therapeutics Nominates First Oncology Clinical Development Candidate from its Cloudbreak® Platform January 4, 2023
Biotech New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy January 4, 2023
Search
